0001209191-21-012366.txt : 20210219 0001209191-21-012366.hdr.sgml : 20210219 20210219163000 ACCESSION NUMBER: 0001209191-21-012366 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210217 FILED AS OF DATE: 20210219 DATE AS OF CHANGE: 20210219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZELDIS JEROME B CENTRAL INDEX KEY: 0001433982 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40045 FILM NUMBER: 21656340 MAIL ADDRESS: STREET 1: 8767 E. VIA DE VENTURA, SUITE 190 CITY: SCOTTSDALE STATE: AZ ZIP: 85258 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NexImmune, Inc. CENTRAL INDEX KEY: 0001538210 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9119 GAITHER ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 301-825-9810 MAIL ADDRESS: STREET 1: 9119 GAITHER ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-17 0 0001538210 NexImmune, Inc. NEXI 0001433982 ZELDIS JEROME B C/O NEXIMMUNE, INC. 9119 GAITHER ROAD GAITHERSBURG MD 20877 0 1 0 0 Executive VP of Research & Dev Common Stock 2021-02-17 4 P 0 5882 17.00 A 5882 D Reflects shares purchased in the Issuer's initial public offering. /s/ Ilse Johnson, Attorney-in-fact 2021-02-19